Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), discusses his diagnosis in 2022 of Stage IV EGFR-positive non-small cell lung cancer in an article published in ASTRO (American Society for Radiation Oncology) News, linked below.

Dr. Camidge also explores the cancer patient experience from his unique perspective as a treatment provider, researcher and patient in a Cracking Cancer podcast episode and a video interview with The Patient Story.

Dr. Camidge is a distinguished leader in lung cancer research and care, serving as the Director of Thoracic Oncology at the University of Colorado, as well as Professor of Medicine/Oncology and the Joyce Zeff Chair in Lung Cancer Research at the University of Colorado. Dr. Camidge leads our Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), noting that “ATOMIC brings together a powerful mixture of mature thought leaders and the next generation of experts with the sole goal of designing and completing clinical trials that will change the way we do business in thoracic oncology for the better.”

Read the article and interview in ASTROnews

Watch the video interview:

Listen to the podcast: